Related Experiment Videos
Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging
A A Schricker1, J M Pauly, J Kurhanewicz
1Department of Radiology, University of California-San Francisco, San Francisco, California 94143-1290, USA.
Magnetic Resonance in Medicine
|December 18, 2001
Summary
New radiofrequency pulses improve prostate cancer MR spectroscopic imaging by reducing errors and power needs. This enhances the reliability and applicability of MRSI for cancer staging and monitoring.
Area of Science:
- Magnetic Resonance Imaging (MRI)
- Medical Physics
- Oncology
Background:
- Prostate MR spectroscopic imaging (MRSI) is valuable for cancer staging and monitoring.
- Current MRSI methods face challenges including chemical shift misregistration and high peak RF power requirements.
- Effective water and lipid suppression is crucial for interpretable prostate MRSI spectra.
Purpose of the Study:
- To develop novel spectral-spatial radiofrequency (RF) pulses for prostate MRSI.
- To address limitations of conventional pulses, specifically chemical shift misregistration and peak power demands.
- To enable dual-band excitation with controlled water suppression for improved data analysis and assessment.
Main Methods:
- Development of new spectral-spatial RF pulses incorporating optimal phase modulation.
- Design focused on negating chemical shift misregistration errors.
- Implementation of dual-band excitation for targeted metabolite and water resonance manipulation.
Main Results:
- The new RF pulses successfully eliminated chemical shift misregistration.
- A 40% reduction in peak RF power was achieved through optimal phase modulation.
- Patient studies confirmed the feasibility and demonstrated clear benefits in reliability and applicability.
Conclusions:
- Novel spectral-spatial RF pulses significantly improve prostate cancer MRSI acquisition.
- These advancements enhance the accuracy and practicality of MRSI for clinical applications.
- The developed pulses offer a more robust approach to prostate cancer staging and monitoring.